The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
Why ICD-10 codes are important
Search the full ICD-10 catalog by:
ICD-9 Code 780.93 -Memory loss- Codify by AAPC.
ICD-10 code R41. 9 for Unspecified symptoms and signs involving cognitive functions and awareness is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
ICD-10 Code for Mild cognitive impairment, so stated- G31. 84- Codify by AAPC.
Neurocognitive disorder is a general term that describes decreased mental function due to a medical disease other than a psychiatric illness. It is often used synonymously (but incorrectly) with dementia. The major areas of the brain have one or more specific functions.
Both mild cognitive impairment and mild dementia are characterized by objective evidence of cognitive impairment. The main distinctions between mild cognitive impairment and mild dementia are that in the latter, more than one cognitive domain is involved and substantial interference with daily life is evident.